Sun Pharmaceutical Industries Share Price Today - Live Blog for July 30, 2025

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,732.25. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.5600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.08% boost, with the current market value at ₹1,733.00 per share. This surge has not gone unnoticed by investors.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.01% drop, and it's now trading at ₹1,731.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd share price surged by 0.01%. With its current market price standing at ₹1,731.60 per share, this stock is garnering increased attention from the investment community.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.12% increase and currently trading at ₹1,731.50 per share. Investors are taking notice of this upward momentum.

With a remarkable 0.06% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,729.35. Notably, this stock has a Price-to-Earnings (PE) ratio of 37.5600, while the industry's PE ratio is 35.5773.

Sun Pharmaceutical Industries Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,727.50. The stock has a PE ratio of 37.5600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.18% dip in its share price and is currently trading at ₹1,729.55. The stock has a PE ratio of 37.5600, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,732.00. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.26% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,732.40. Investors should examine the factors driving this decline. The stock's PE ratio is 37.5600, whereas the industry PE ratio stands at 35.5773.

After a significant 0.01% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,737.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.18%, and it is currently trading at ₹1,737.25. Additionally, the stock maintains a PE ratio of 37.5600, while the industry PE is 35.5773.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.18% surge in its share price and is presently trading at ₹1,737.25. The increased investor interest is driving this surge.

After a notable 0.28% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,734.90. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.28%, reaching the current market price of ₹1,734.90. This development underscores the stock's growing popularity.

After a significant 0.28% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,734.90 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.39%, reaching a current market price of ₹1,729.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.23%, reaching the current market price of ₹1,732.80. This surge is indicative of the stock's recent positive performance.

Following a noteworthy 0.23% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,732.80. When it comes to valuation, this stock has a PE ratio of 37.5600, with the industry PE ratio at 35.5773.

With a -0.21% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,728.95. The stock is currently trading at a PE of 37.5600, while the industry PE is 35.5773, prompting investors to assess its value proposition.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.06% drop, and it's now trading at ₹1,732.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.01% boost, with the current market value at ₹1,729.90 per share. This surge has not gone unnoticed by investors.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.01%, reaching the current market price of ₹1,729.90. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.19% uptick, and they are currently valued at ₹1,729.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.22% surge in its share price and is presently trading at ₹1,725.80. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,720.20, making it an appealing option for investors.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.01% recently. As of now, this stock is actively trading at a current market price of ₹1,720.20 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 2.26% uptick, and they are currently valued at ₹1,720.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.